QUIDELORTHO CORP Share-based Payment Arrangement, Cash Used to Settle Award
QUIDELORTHO CORP (QDEL) reported Share-based Payment Arrangement, Cash Used to Settle Award of $7.30 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Additional Disclosure
us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards · last filed 2026-02-19
- QUIDELORTHO CORP share-based payment arrangement, cash used to settle award for fiscal 2023 was $7.30M, a 65.07% decline from fiscal 2023.
- QUIDELORTHO CORP share-based payment arrangement, cash used to settle award for fiscal 2023 was $20.90M.
| Period end | Share-based Payment Arrangement, Cash Used to Settle Award 12 month |
|---|---|
| 2023-12-31 | $7.30M 10-K · filed 2026-02-19 |
| 2023-01-01 | $20.90M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |